411 related articles for article (PubMed ID: 30418608)
1. Wearable and implantable diagnostic monitors in early assessment of atrial tachyarrhythmia burden.
Healey JS; Wong J
Europace; 2019 Mar; 21(3):377-382. PubMed ID: 30418608
[TBL] [Abstract][Full Text] [Related]
2. Practice Variation in Anticoagulation Prescription and Outcomes After Device-Detected Atrial Fibrillation.
Perino AC; Fan J; Askari M; Heidenreich PA; Keung E; Raitt MH; Piccini JP; Ziegler PD; Turakhia MP
Circulation; 2019 May; 139(22):2502-2512. PubMed ID: 30880434
[TBL] [Abstract][Full Text] [Related]
3. Intermittent anticoagulation guided by continuous atrial fibrillation burden monitoring using dual-chamber pacemakers and implantable cardioverter-defibrillators: Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) pilot study.
Waks JW; Passman RS; Matos J; Reynolds M; Thosani A; Mela T; Pederson D; Glotzer TV; Zimetbaum P
Heart Rhythm; 2018 Nov; 15(11):1601-1607. PubMed ID: 29981863
[TBL] [Abstract][Full Text] [Related]
4. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.
Edwards SJ; Wakefield V; Jhita T; Kew K; Cain P; Marceniuk G
Health Technol Assess; 2020 Jan; 24(5):1-184. PubMed ID: 31944175
[TBL] [Abstract][Full Text] [Related]
5. Arrhythmic Burden and the Risk of Cardiovascular Outcomes in Patients With Paroxysmal Atrial Fibrillation and Cardiac Implanted Electronic Devices.
Chew DS; Li Z; Steinberg BA; O'Brien EC; Pritchard J; Bunch TJ; Mark DB; Patel MR; Nabutovsky Y; Greiner MA; Piccini JP
Circ Arrhythm Electrophysiol; 2022 Feb; 15(2):e010304. PubMed ID: 35089799
[TBL] [Abstract][Full Text] [Related]
6. Atrial fibrillation burden, progression, and the risk of death: a case-crossover analysis in patients with cardiac implantable electronic devices.
Piccini JP; Passman R; Turakhia M; Connolly AT; Nabutovsky Y; Varma N
Europace; 2019 Mar; 21(3):404-413. PubMed ID: 30462208
[TBL] [Abstract][Full Text] [Related]
7. Rationale and Design of the Evaluation of Oral Anticoagulation for Reduction of Thrombo-embolism in Chinese Patients with Device-Detected Subclinical Atrial Fibrillation (ART-CAF) Trial: an Open-Label Registry-Based Clinical Trial.
Yang Y; Xu F; Tong J; Cai L; Jiang W; Sheng X; Pan Y; Jiang J; Zhang J; Jiang D; Zhao L; Fu G
Cardiovasc Drugs Ther; 2018 Aug; 32(4):389-396. PubMed ID: 30027309
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Evaluation of Rhythm Monitoring Strategies in Screening for Atrial Fibrillation: Insights From Patients at Risk Monitored Long Term With an Implantable Loop Recorder.
Diederichsen SZ; Haugan KJ; Kronborg C; Graff C; Højberg S; Køber L; Krieger D; Holst AG; Nielsen JB; Brandes A; Svendsen JH
Circulation; 2020 May; 141(19):1510-1522. PubMed ID: 32114796
[TBL] [Abstract][Full Text] [Related]
9. Role of cardiac electronic implantable device in the stratification and management of embolic risk of silent atrial fibrillation: are all atrial fibrillations created equal?
Di Cori A; Lilli A; Zucchelli G; Zaca V
Expert Rev Cardiovasc Ther; 2018 Mar; 16(3):175-181. PubMed ID: 29431527
[TBL] [Abstract][Full Text] [Related]
10. Subclinical atrial fibrillation and stroke: insights from continuous monitoring by implanted cardiac electronic devices.
Lau CP; Siu CW; Yiu KH; Lee KL; Chan YH; Tse HF
Europace; 2015 Oct; 17 Suppl 2():ii40-6. PubMed ID: 26842114
[TBL] [Abstract][Full Text] [Related]
11. Physician decision making in anticoagulating atrial fibrillation: a prospective survey of a physician notification system for atrial fibrillation detected on cardiac implantable electronic devices of patients at increased risk of stroke.
Cloutier JM; Khoo C; Hiebert B; Wassef A; Seifer CM
Ther Adv Cardiovasc Dis; 2018 Apr; 12(4):113-122. PubMed ID: 29528778
[TBL] [Abstract][Full Text] [Related]
12. Detection of new atrial fibrillation in patients with cardiac implanted electronic devices and factors associated with transition to higher device-detected atrial fibrillation burden.
Boriani G; Glotzer TV; Ziegler PD; De Melis M; Mangoni di S Stefano L; Sepsi M; Landolina M; Lunati M; Lewalter T; Camm AJ
Heart Rhythm; 2018 Mar; 15(3):376-383. PubMed ID: 29122724
[TBL] [Abstract][Full Text] [Related]
13. Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials?
Boriani G; Gerra L; Mei DA; Bonini N; Vitolo M; Proietti M; Imberti JF
Eur J Intern Med; 2024 May; 123():37-41. PubMed ID: 38281819
[TBL] [Abstract][Full Text] [Related]
14. Predictors of atrial fibrillation detection and features of recurrent strokes in patients after cryptogenic stroke.
Xu J; Sethi P; Biby S; Allred J; Seiler A; Sabir R
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):104934. PubMed ID: 32807411
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of a prospective study of the clinical significance of atrial arrhythmias detected by implanted device diagnostics: the TRENDS study.
Glotzer TV; Daoud EG; Wyse DG; Singer DE; Holbrook R; Pruett K; Smith K; Hilker CE
J Interv Card Electrophysiol; 2006 Jan; 15(1):9-14. PubMed ID: 16680544
[TBL] [Abstract][Full Text] [Related]
16. Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention.
Ziegler PD; Glotzer TV; Daoud EG; Singer DE; Ezekowitz MD; Hoyt RH; Koehler JL; Coles J; Wyse DG
Am J Cardiol; 2012 Nov; 110(9):1309-14. PubMed ID: 22819433
[TBL] [Abstract][Full Text] [Related]
17. Clinical classification and the subclinical atrial fibrillation challenge: a position paper of the European Cardiac Arrhythmia Society.
Lévy S; Santini L; Cappato R; Steinbeck G; Capucci A; Saksena S
J Interv Card Electrophysiol; 2020 Dec; 59(3):495-507. PubMed ID: 33048302
[TBL] [Abstract][Full Text] [Related]
18. Device-detected atrial fibrillation and risk for stroke: an analysis of >10,000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices).
Boriani G; Glotzer TV; Santini M; West TM; De Melis M; Sepsi M; Gasparini M; Lewalter T; Camm JA; Singer DE
Eur Heart J; 2014 Feb; 35(8):508-16. PubMed ID: 24334432
[TBL] [Abstract][Full Text] [Related]
19. When is Device-Detected Atrial Fibrillation Actionable?
Wasserlauf J; Passman RS
Card Electrophysiol Clin; 2018 Mar; 10(1):75-85. PubMed ID: 29428144
[TBL] [Abstract][Full Text] [Related]
20. Covert atrial fibrillation and atrial high-rate episodes as a potential cause of embolic strokes of undetermined source: Their detection and possible management strategy.
Tomita H; Sasaki S; Hagii J; Metoki N
J Cardiol; 2018 Jul; 72(1):1-9. PubMed ID: 29609876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
